🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sunita Vohra

University of Alberta

ORCID: 0000-0002-6210-7933
MedicineDecision SciencesEconomics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.417Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Ewha Medical Journal(2025)10.12771/emj.2025.00409
Top 44%
0.417DataRank
Top 44%7 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

Papers

Driven by 17 papers — median percentile 56. Top paper: “CONSORT 2025 Statement”.

CONSORT 2025 Statement

JAMA(2025)10.1001/jama.2025.4347
N/A
3.8DataRank · unranked
230 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +35 more

CONSORT 2025 statement: updated guideline for reporting randomised trials

The Lancet(2025)10.1016/s0140-6736(25)00672-5
N/A
3.6DataRank · unranked
337 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +35 more

CONSORT 2025 statement: updated guideline for reporting randomized trials

Nature Medicine(2025)10.1038/s41591-025-03635-5
N/A
3.3DataRank · unranked
215 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +35 more

SPIRIT 2025 statement: updated guideline for protocols of randomised trials

BMJ(2025)10.1136/bmj-2024-081477
N/A
2.4DataRank · unranked
292 citations

Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins +34 more

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

BMJ(2025)10.1136/bmj-2024-081124
N/A
1.5DataRank · unranked
126 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

CONSORT 2025 statement: updated guideline for reporting randomised trials

BMJ(2025)10.1136/bmj-2024-081123
N/A
0.955DataRank · unranked
580 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

PRISMA harms checklist: improving harms reporting in systematic reviews

BMJ(2016)10.1136/bmj.i157
N/A
0.947DataRank · unranked
550 citations

Yoon K. Loke, Su Golder, Pasqualina Santaguida, Douglas G. Altman, David Moher +4 more

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

BMJ(2023)10.1136/bmj-2022-073725
N/A
0.749DataRank · unranked
146 citations

Liliane Zorzela, Steven A. Julious, Tianjing Li, Ba Pham, Rachel Phillips +11 more

CONSORT 2025 statement: Updated guideline for reporting randomised trials

PLOS Medicine(2025)10.1371/journal.pmed.1004587
N/A
0.702DataRank · unranked
107 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

SPIRIT 2025 statement: updated guideline for protocols of randomized trials

Nature Medicine(2025)10.1038/s41591-025-03668-w
N/A
0.680DataRank · unranked
92 citations

Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins +35 more

Time to improve the reporting of harms in randomized controlled trials

Journal of Clinical Epidemiology(2021)10.1016/j.jclinepi.2021.04.020
N/A
0.587DataRank · unranked
49 citations

Rachel Phillips, Liliane Zorzela, Su Golder, Yoon K. Loke, David Moher +3 more

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials

Journal of Clinical Epidemiology(2023)10.1016/j.jclinepi.2023.04.005
N/A
0.564DataRank · unranked
42 citations

Liliane Zorzela, Steven A. Julious, Tianjing Li, Ba Pham, Rachel Phillips +17 more

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials

PLOS Medicine(2025)10.1371/journal.pmed.1004589
N/A
0.457DataRank · unranked
20 citations

Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins +34 more

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation

Ewha Medical Journal(2025)10.12771/emj.2025.00409
Top 44%
0.417DataRank
Top 44%7 citations

An-Wen Chan, Gary S. Collins, Asbjørn Hróbjartsson, David Moher, Kenneth F. Schulz +34 more

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

UNC Libraries(2024)10.17615/p6dm-ff76
N/A
0DataRank · unranked
0 citations

Liliane Zorzela, Su Golder, Y. K. Loke, Joel Gagnier, Steven A. Julious +12 more

Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study

BMJ(2022)10.1136/bmj-2021-069155
N/A
0DataRank · unranked
76 citations

Tianqi Yu, Luis Furuya‐Kanamori, Lifeng Lin, Liliane Zorzela, Xiaoqin Zhou +4 more

N-of-1 Trials, Their Reporting Guidelines, and the Advancement of Open Science Principles

PubMed(2022)10.1162/99608f92.a65a257a
N/A
0DataRank · unranked
3 citations

Sunita Vohra, Antony Porcino